Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Activation of NLRP3 Inflammasome and Onset of Alzheimer’s Disease
Hua Bai, Qifang Zhang
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

New Insights into Neuroinflammation Involved in Pathogenic Mechanism of Alzheimer’s Disease and Its Potential for Therapeutic Intervention
Tiantian Li, Li Lu, Eloise Pember, et al.
Cells (2022) Vol. 11, Iss. 12, pp. 1925-1925
Open Access | Times Cited: 62
Targeting NLRP3-Mediated Neuroinflammation in Alzheimer’s Disease Treatment
Julia Barczuk, Natalia Siwecka, Weronika Lusa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 8979-8979
Open Access | Times Cited: 46
The involvement of NLRP3 inflammasome in CUMS-induced AD-like pathological changes and related cognitive decline in mice
Jiamei Li, Ting Hu, Xiao-Na Zhou, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 32
MCC950 reduces autophagy and improves cognitive function by inhibiting NLRP3-dependent neuroinflammation in a rat model of Alzheimer's disease
Abdul Naeem, Ravi Prakash, Neha Kumari, et al.
Brain Behavior and Immunity (2023) Vol. 116, pp. 70-84
Closed Access | Times Cited: 28
Essential oil of Acorus tatarinowii Schott inhibits neuroinflammation by suppressing NLRP3 inflammasome activation in 3 × Tg-AD transgenic mice
Zhiwei Xu, Xiaojie Zhou, Hong Xiao, et al.
Phytomedicine (2023) Vol. 112, pp. 154695-154695
Closed Access | Times Cited: 26
Neuroinflammation of Microglial Regulation in Alzheimer’s Disease: Therapeutic Approaches
Haiyun Chen, Yuhan Zeng, Dan Wang, et al.
Molecules (2024) Vol. 29, Iss. 7, pp. 1478-1478
Open Access | Times Cited: 14
The interplay between mitochondrial dysfunction and NLRP3 inflammasome in multiple sclerosis: Therapeutic implications and animal model studies
Alireza Shadab, Mohammad Abbasi‐Kolli, Mansoore Saharkhiz, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116673-116673
Open Access | Times Cited: 9
Microglial NLRP3 Inflammasomes in Alzheimer’s Disease Pathogenesis: From Interaction with Autophagy/Mitophagy to Therapeutics
Gunel Ayyubova, Leelavathi N. Madhu
Molecular Neurobiology (2025)
Closed Access | Times Cited: 1
Role of Peripheral NLRP3 Inflammasome in Cognitive Impairments: Insights of Non-central Factors
Min Qiao, Junjun Ni, Hong Qing, et al.
Molecular Neurobiology (2025)
Closed Access | Times Cited: 1
Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer’s Disease: Towards a Personalized Polypharmacology Patient-Centered Approach
Xavier Morató, Vanesa Pytel, Sara Jofresa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9305-9305
Open Access | Times Cited: 34
The central role of the gut in intensive care
Alberto Corriero, Raffaella Maria Gadaleta, Filomena Puntillo, et al.
Critical Care (2022) Vol. 26, Iss. 1
Open Access | Times Cited: 32
The emerging role of autophagy and mitophagy in tauopathies: From pathogenesis to translational implications in Alzheimer’s disease
Xiao‐Lan Liu, Meng Ye, Liang Ma
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 29
Gut Microbiota Modulation and Its Implications on Neuropathic Pain: A Comprehensive Literature Review
Alberto Corriero, Mariateresa Giglio, Francesco Inchingolo, et al.
Pain and Therapy (2023) Vol. 13, Iss. 1, pp. 33-51
Open Access | Times Cited: 21
Interactions between gut microbes and NLRP3 inflammasome in the gut-brain axis
Yang Ding, Zixu Wang, Yaoxing Chen, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 2215-2227
Open Access | Times Cited: 20
Pyroptosis in neurodegenerative diseases: from bench to bedside
Kejia Wu, Wan-rong Wang, Qian-hui Cheng, et al.
Cell Biology and Toxicology (2023) Vol. 39, Iss. 6, pp. 2467-2499
Closed Access | Times Cited: 18
Common Signaling Pathways Involved in Alzheimer’s Disease and Stroke: Two Faces of the Same Coin
Tushar Kanti Das, Bhanu Priya Ganesh, Kaneez Fatima-Shad
Journal of Alzheimer s Disease Reports (2023) Vol. 7, Iss. 1, pp. 381-398
Open Access | Times Cited: 17
The emerging role of brain neuroinflammatory responses in Alzheimer’s disease
Mandana Amelimojarad, Melika Amelimojarad, Xiaonan Cui
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 8
The neuroinflammatory role of microglia in Alzheimer's disease and their associated therapeutic targets
Melika Amelimojarad, Mandana AmeliMojarad
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 7
Open Access | Times Cited: 8
TLR4/Rac1/NLRP3 Pathway Mediates Amyloid-β-Induced Neuroinflammation in Alzheimer’s Disease
Mengxin Zhu, Yang Liu, Chen Chen, et al.
Journal of Alzheimer s Disease (2024) Vol. 99, Iss. 3, pp. 911-925
Closed Access | Times Cited: 7
The role of the NLRP3 inflammasome in chronic inflammation in asthma and chronic obstructive pulmonary disease
Yaxin Wu, Xin Di, Min Zhao, et al.
Immunity Inflammation and Disease (2022) Vol. 10, Iss. 12
Open Access | Times Cited: 23
Advances in the Understanding of the Correlation Between Neuroinflammation and Microglia in Alzheimer’s Disease
H YAN, Wei Wang, Tingting Cui, et al.
ImmunoTargets and Therapy (2024) Vol. Volume 13, pp. 287-304
Open Access | Times Cited: 5
Diverse pathways to neuronal necroptosis in Alzheimer's disease
Anusha Jayaraman, Richard Reynolds
European Journal of Neuroscience (2022) Vol. 56, Iss. 9, pp. 5428-5441
Closed Access | Times Cited: 19
Cause or consequence? The role of IL-1 family cytokines and receptors in neuroinflammatory and neurodegenerative diseases
Diana Boraschi, Paola Italiani, Paola Migliorini, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Targeting terminal pathway reduces brain complement activation, amyloid load and synapse loss, and improves cognition in a mouse model of dementia
Wioleta M. Zelek, Ryan J. Bevan, B. Paul Morgan
Brain Behavior and Immunity (2024) Vol. 118, pp. 355-363
Open Access | Times Cited: 4
Targeting lysosomal quality control as a therapeutic strategy against aging and diseases
Yuchen He, Yishu Fan, Xenab Ahmadpoor, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 6, pp. 2472-2509
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top